Merkliste 
 1 Ergebnisse 
 
1

Phase II Trial of Temozolomide (TMZ), Motexafin Gadolinium ..:

Brachman, D.G. ; Wang, M. ; Ashby, L.S....
International Journal of Radiation Oncology*Biology*Physics.  81 (2011)  2 - p. S129-S130 , 2011